Re: Status dystonicus and Hallervorden-Spatz disease.
Flett
P J
PJ
D001418:Baclofen / Q000627:therapeutic use*; D002648:Child; D020821:Dystonic Disorders / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000150:complications* / Q000188:drug therapy; D016896:Treatment Outcome
D009125:Muscle Relaxants, Central; D001418:Baclofen